Trial Profile
An Open-Label, Single Dose Study to Assess Pharmacokinetics, Safety and Tolerability of Lorcaserin Hydrochloride in Obese Pediatric Subjects 6 to 11 Years of Age
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2015
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 04 Aug 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Mar 2015 New trial record